Former FDA chief predicts states will make COVID-19 vaccines 'generally available' by April


One of the major challenges the United States is facing in its COVID-19 vaccine drive is the fact that demand is outstripping supply, but Former Food and Drug Commissioner Scott Gottlieb thinks that will flip suddenly and "sooner than we think."
In an appearance on CNBC's Squawk Box on Monday, Gottlieb noted that vaccine production is ramping up — about 220 million doses will be put into the market by the end of March, and another 100 million will be made available in April. Those numbers will be higher if the FDA soon authorizes Johnson & Johnson's candidate for emergency use, as Gottlieb expects.
By that point, he said, states will likely have to make the shots "generally available" because a shrinking, but still significant reluctance to get vaccinated among the American public means there won't be enough takers if only specific groups of people have access. "If we continue to ration it based on more and more narrow slices of the population, it's going to get harder to administer. So, I think we're just going to have to open this up to general availability, which is good news," he said, pinpointing the end of March and "certainly" April as target dates.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Gottlieb cautioned that doesn't mean everyone who wants a vaccine will be able to get one by April 1, but he does think most people will be able to schedule an appointment. Tim O'Donnell
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
What will security guarantees for Ukraine look like?
Today's Big Question From boots on the ground to economic sanctions, here are the measures that might stop Russia taking another bite out of Ukraine
-
The US Open's controversial 'superstars' doubles format
Talking Point New shortened competition attracts star pairings and bigger audiences to grand slam tennis event
-
Sudoku medium: August 21, 2025
The Week's daily medium sudoku puzzle
-
Texas declares end to measles outbreak
Speed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agency
Speed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC